Weight neutrality with the DPP-4 inhibitor, vildagliptin: mechanistic basis and clinical experience. [electronic resource]
Producer: 20101203Description: 541-8 p. digitalISSN:- 1178-2048
- Adamantane -- analogs & derivatives
- Blood Glucose -- analysis
- Body Weight -- drug effects
- Diabetes Mellitus, Type 2 -- drug therapy
- Dipeptidyl-Peptidase IV Inhibitors -- pharmacology
- Glucose -- metabolism
- Humans
- Hypoglycemic Agents -- adverse effects
- Insulin Resistance
- Nitriles -- pharmacology
- Pyrrolidines -- pharmacology
- Vildagliptin
- Weight Gain -- drug effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.